Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis.

Di Filippo, M; Pini, L A; Pelliccioli, G P; Calabresi, P; Sarchielli, P

Di Filippo, M; Pini, L A; Pelliccioli, G P; Calabresi, P; Sarchielli, P.

Affiliation

Di Filippo M; Centre for Study of Demyelinating Diseases, Department of Medical and Surgical Specialities and Public Health, Ospedale S Maria della Misericordia, University of Perugia, Perugia, Italy.

J Neurol Neurosurg Psychiatry ; 79(11): 1224-9, 2008 Nov.

Article in En | MEDLINE | ID: mdl-18535023

Subject(s)

Cannabinoid Receptor Modulators/cerebrospinal fluid; Endocannabinoids; Multiple Sclerosis/cerebrospinal fluid; Adult; Arachidonic Acids/cerebrospinal fluid; Brain/pathology; Disability Evaluation; Disease Progression; Female; Gas Chromatography-Mass Spectrometry; Glycerides/cerebrospinal fluid; Humans; Inflammation/cerebrospinal fluid; Magnetic Resonance Imaging; Male; Multiple Sclerosis/diagnosis; Oleic Acids/cerebrospinal fluid; Polyunsaturated Alkamides/cerebrospinal fluid; Severity of Illness Index

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endocannabinoids / Cannabinoid Receptor Modulators / Multiple Sclerosis Type of study: Diagnostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: J Neurol Neurosurg Psychiatry Year: 2008 Document type: Article

Fulltext

XML

PubMed Links

Search on Google